|
|||||
 |
|||||
 |
|||||
|
 |
Online Web Activities - Dev CHOLECYSTOKININ-CHOLESCINTIGRAPHY (CCK-CS) IN CHRONIC ABDOMINAL PAIN: Basics and Standard Application State-of-the-Art Review To participate in this on-demand web program (valid thru June 1, 2023) click here This program will provide guidance for clinicians who diagnose and
treat biliary pain and functional gall bladder disorders and will use
case studies to demonstrate how to appropriately apply CCK-CS to
clinical decision making, including the decision to recommend
cholecystectomy. For nuclear medicine physicians, pharmacists, and
radiologic technologists. CHOLECYSTOKININ-CHOLESCINTIGRAPHY (CCK-CS) IN CHRONIC ABDOMINAL PAIN: Case-Based Review of Practice Pearls To participate in this on-demand web program (valid thru November 1, 2023) click here This program will provide clinicians with the diagnostic precision of using (CCK-CS) in determining the pathology of chronic abdominal pain which requires a systematic approach and represents an unmet medical need. In this webinar, several case studies will be presented to demonstrate a systematic approach using a structured reporting checklist to ensure consistent detection of rare but consequential diagnoses. For nuclear medicine physicians, pharmacists, and radiologic technologists. "Coronary Flow Capacity Assessment of Coronary Artery Physiology with Cardiac Positron Emission Tomography" To participate in this on-demand web program (valid thru August 7, 2023) click here The presentation will provide clarity concerning the tools to measure MBF and their interrelationship. The concept of coronary flow capacity (CFC) will be presented and its relevance and impact on clinical practice and patient care will be discussed. Clinicians who participate in this program will gain an appreciation for the use of positron emission tomography (PET) scanning with CFC to help identify patients who will benefit from revascularization. For nuclear medicine physicians, pharmacists, and radiologic technologists. "Coronary Flow Capacity: HOW DOES IT DIFFER FROM CFR AND WHY IS IT BETTER FOR PATIENT MANAGEMENT?" To participate in this on-demand web program (valid thru February 21, 2024) click here This presentation will provide insight into the measurement of myocardial blood flow (MBF) and its interpretation. The presentation will provide clarity concerning various metrics of MBF, the relationship between the metrics and how these metrics may be discordant with each other and with angiographic findings. The concept of coronary flow capacity (CFC) will be presented and its relevance and impact on clinical practice and patient care will be discussed. Clinicians who participate in this program will gain an appreciation for the use of positron emission tomography (PET) scanning with CFC to help identify patients who will benefit from revascularization. For nuclear medicine physicians, pharmacists, and radiologic technologists. "Why Does My Patient Have Angina?" To participate in this on-demand web program (valid thru July 27, 2023) click here Dr. Johnson will provide educational insight into a contemporary approach to the diagnosis and management of angina taking into consideration epicardial coronary disease, microcirculatory dysfunction, and coronary vasospasm. This insight will enhance physician appraisal of ischemic heart disease (IHD) through the consideration of all pathophysiology relevant to symptoms, prognosis and treatment and result in improved health outcomes for patients. "We've Measured Flow. Now What Does It Mean?" To participate in this on-demand web program (valid thru October 3, 2023) click here This lecture will detail the scientific literature describing myocardial perfusion dating back to the first measurements in 1949. The goal is to synthesize the entire spectrum of myocardial perfusion in order to understand objective limits for distinguishing normal from abnormal. We first discuss myocardial perfusion in normal people (not patients!) aged less than 40 with no risk factors. From this cohort we can understand truly normal perfusion, not accessible or measured invasively due to unethical risk of invasive catheterization for people. At the other end of the spectrum, transmural or nontransmural infarcts as verified by cardiac magnetic resonance imaging permit a boundary of low resting flows identifies nonviable myocardium. Frank ischemia (angina, ST-segment depression, and a relative perfusion defect) and its associated myocardial perfusion can be imaged to understand how stress flows must fall in order to reach this low level. A wide continuum falls between normal flows and ischemia and relates to risk factor burden, anatomic atherosclerosis, clinical heart disease, and previous revascularization procedures. |
|||
|
|||||
